The discriminative stimulus effects of tripelennamine in humans

Psychopharmacology

Volumn 126, Issue 2, 1996, Pages 140-146

  Johanson, Chris Ellyn ^a   Evans, Suzette ^b   Henningfield, Jack ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b Box 66 ^*  (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Antihistamines; Drug discrimination; Humans; Subjective effects; Tripelennamine

Indexed keywords

CHLORPHENIRAMINE; DEXAMPHETAMINE; DIAZEPAM; DIPHENHYDRAMINE; PLACEBO; TRIPELENNAMINE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG CAPSULE; DRUG DISCRIMINATION; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; PRIORITY JOURNAL; VOLUNTEER;

ADULT; CHLORPHENIRAMINE; DEXTROAMPHETAMINE; DIAZEPAM; DIPHENHYDRAMINE; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; PLACEBOS; TRIPELENNAMINE;

EID: 0030037199     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246349     Document Type: Article

References (29)

1. Barnett A, Iorio LC, Kreutner W, Tozzi S, Ahn HS, Gulbenkian A (1984) Evaluation of the CNS properties of SCH29851, a potential non-sedating antihistamine. Agents Actions 14: 590-597
2. 1 antagonists in squirrel monkeys. J Pharmacol Exp Ther 239: 104-110
3. Bickel WK, Bigelow GE, Preston KE, Liebson IA (1989) Opioid drug discrimination in humans: stability, specificity and relation to self-reported drug effect. J Pharmacol Exp Ther 251: 1053-1063
4. Carruthers SG, Shoeman DW, Hignite CE, Azarnoff DL (1978) Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther 23: 375-382
5. Chait LD, Uhlenhuth EH, Johanson CE (1984) An experimental paradigm for studying the discriminative stimulus properties of drugs in humans. Psychopharmacology 82: 272-274
6. Chait LD, Uhlenhuth EH, Johanson CE (1985) The discriminative stimulus and subjective effects of d-amphetamine in humans. Psychopharmacology 86: 307-312
7. Chait LD, Uhlenhuth EH, Johanson CE (1986a) The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans. Psychopharmacology 89: 301-306
8. Chait LD, Uhlenhuth EH, Johanson CE (1986b) The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol, and d-amphetamine in humans. Pharmacol Biochem Behav 24: 1665-1672
9. Chait LD, Uhlenhuth EH, Johanson CE (1989) Individual differences in the discriminative stimulus effects of d-amphetamine in humans. Drug Dev Res 16: 451-460
10. Colpaert FC, Balster RL (eds) (1988) Transduction mechanisms of drug stimuli. Springer, Berlin
11. 1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital. J Pharmacol Exp Ther 250: 779-787
12. 1-antagonists in pigeons. Behav Pharmacol 2: 447-460
13. Haertzen CA (1966) Development of scales based on patterns of drug effects using the Addiction Research Center Inventory (ARCI). Psych Rep 18: 163-194
14. Johanson CE (1991a) The discriminative stimulus effects of diazepam in humans. J Pharmacol Exp Ther 257:634-643
15. Johanson CE (1991b) Further studies of the discriminative stimulus effects of diazepam in humans. Behav Pharmacol 2: 357-367
16. Johanson CE (1993) The discriminative stimulus effects of buspirone in humans. Exp Clin Psychopharmacol 1:173-187
17. Kamien JB, Bickel WK, Hughes JR, Higgins ST, Smith B (1993) Drug discrimination by humans compared to nonhumans: current status and future directions. Psychopharmacology 111: 259-270
18. Kamien JB, Bickel WK, Olivelo AH, Higgins ST, Hughes JR, Richards AT, Badger, GJ (1995) Placebo-effects contribute to differences in the acquisition of drug discrimination by humans: a retrospective analysis. Behav Pharmacol 6: 187-194
19. Kulshrestha VK, Gupta PP, Turner P, Wadsworth J (1978) Some clinical pharmacological studies with terfenadine, a new anti-histamine drug. Br J Clin Pharmacol 6: 25-29
20. Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective and behavioral effects of amphetamine, ephedrine, phenmetrazine, and methylphenidate in man, Clin Pharmacol Ther 12: 245-258
21. McNair DM, Lorr M, Droppleman LF (1971) Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego
22. Melville KI (1973) Antihistamine drugs. In: Peters G, Schachter M (eds) International encyclopedia of pharmacology and therapeutics, section 74: histamine and antihistamines. Pergamon Press, Oxford, pp 127-171
23. Preston KL, Bigelow GE, Bickel WK, Liebson IA (1987) Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline. J Pharmacol Exp Ther 243: 1002-1009
24. Preston KL, Bigelow GE, Bickel WK, Liebson IA (1989) Drug discrimination in human postaddicts: agonist-antagonist opioids. J Pharmacol Exp Ther 250: 184-196
25. Schuster CR, Johanson CE (1988) Relationship between the discriminative stimulus properties and subjective effects of drugs. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli. Springer (Psychopharmacology Supplementum Series), Berlin, pp 161-175
26. Stern KN, Chait LD, Johanson CE (1989) Reinforcing and subjective effects of oral tripelennamine in normal volunteers. Behav Pharmacol 1: 161-167
27. Stolerman IP, Rasul F, Shine PJ (1989) Trends in drug discrimination research analysed with a cross-indexed bibliography. Psychopharmacology 98: 1-19
28. Stolerman IP, Shine PJ (1985) Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982 1983. Psychopharmacology 86: 1-11
29. Young AM (1991) Discriminative stimulus profiles of psychoactive drugs. In: Mello NK (ed) Advances in substance abuse: behavioral and biological research, vol. 4. Jessica Kingsley Publishers, London, pp 139-203